PIP
LMAT icon

Palisades Investment Partners’s LeMaitre Vascular LMAT Stock Holding History

Palisades Investment Partners’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$486K Buy
4,453
+529
+13% +$50.4K 0.19% 49
2025
Q4 		$318K Buy
3,924
+459
+13% +$39.5K 0.12% 48
2025
Q3 		$303K Buy
+3,465
New +$309K 0.12% 47

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Palisades Investment Partners's LMAT Position: Q1 2026 in Review

Palisades Investment Partners increased its LeMaitre Vascular (LMAT) stake by 13% in Q1 2026, buying an estimated $50.4K and bringing the position to 4,453 shares worth $486K. The position accounts for 0.19% of the portfolio, ranked #49.

Palisades Investment Partners first reported a position in LMAT in Q3 2025 and has held it in 3 quarters since. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

  • Palisades Investment Partners held 4,453 shares of LeMaitre Vascular worth $486K as of Q1 2026.
  • Palisades Investment Partners bought 529 LeMaitre Vascular shares in Q1 2026, an estimated $50.4K.
  • LeMaitre Vascular made up 0.19% of Palisades Investment Partners's portfolio in Q1 2026, its #49 holding.
  • Palisades Investment Partners first reported a position in LeMaitre Vascular in Q3 2025 and has held it in 3 quarters since.
  • 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on Palisades Investment Partners's 13F filing for Q1 2026, filed 30 Apr 2026.